ORLANDO, Fla., April 3 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced today that its Board of Directors has appointed Jon Stemples as Non-Executive Chairman of Telzuit’s Board. Mr. Stemples has served as a member of Telzuit’s Board of Directors since 2005. A 35-year veteran of the semiconductor industry, including past senior positions at Agere Systems and Lucent Microelectronics, Mr. Stemples has a wide range of technical, managerial and sales expertise that will be instrumental to Telzuit as the Company moves to an operational stage.
Warren D. Stowell, Chief Executive Officer of Telzuit, commented, “Jon has been an extremely valued member of the Telzuit’s Board, and his appointment as Non-Executive Chairman is a natural fit for our Board and our Company. Jon’s distinguished career spans over three decades in the product development side of the semiconductor industry. We will draw from his experience and his successful sales and marketing track record as we develop and launch our own series of mobile medical devices, including our signature Bio-Patch System.”
Mr. Stemples commented, “I thank the Telzuit Board for this opportunity to serve the Company in an expanded role. With the broad launch of our signature Bio-Patch on the near-term horizon, I believe the Company is on the cusp of an exciting period of growth and development in the area of mobile medical technology. I will continue to utilize my knowledge and experience to advance the progress of Telzuit’s pioneering wireless monitoring devices, and to support the Company’s position as a leader in this revolutionary medical field.”
Today’s appointment of Mr. Stemples further solidifies Telzuit’s senior leadership. The Company recently appointed Warren D. Stowell, a veteran executive in the Healthcare industry, to Chief Executive Officer, as well as Kenneth Adams, formerly a Vice President and Chief Financial Officer of Saab Cars USA, to the Company’s Board of Directors. Telzuit also announced on March 20, 2006, that it had commenced its initial soft launch of the Bio-Patch in Orlando, securing 500 orders of the device with local physicians in the Company’s home market.
Jon Stemples Bio:
Jon Stemples has over 35 years of experience in the semiconductor industry, having served at Agere Systems, Lucent Microelectronics, Ortel Corporation, Level One Communications and Linear Technology & National Semiconductor as Director of Marketing; Area, Regional and District Sales Manager; Product Marketing Manager and Field Applications Engineer. His technical expertise ranges form communications chips to data acquisition to microprocessors. Mr. Stemples holds a BSEE from the University of Miami.
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine for people worldwide. The company is in the final stages of launching its first product, the FDA-approved Bio-Patch Wireless Heart Monitor. The Bio-Patch is a full 12-lead, completely wireless Holter monitor, which is new to the marketplace. In conjunction with its strategic partners, Telzuit is also building its own dedicated intranet platform to handle several of the products it will be releasing, including the Bio-Patch. Telzuit is based in Orlando, Florida. For more information Telzuit, its business model, and its products, please visit the company’s website: http://www.telzuit.com.
Forward Looking Statement: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertake no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.
Contact: Telzuit Medical Technologies, Inc. James Tolan, Senior Vice President 407-354-1222 Brainerd Communicators, Inc. Jennifer Gery (media) Todd St. Onge (investors) 212-986-6667
Telzuit Medical Technologies, Inc.
CONTACT: James Tolan, Senior Vice President of Telzuit MedicalTechnologies, Inc., +1-407-354-1222; or Jennifer Gery, media, or Todd St.Onge, investors, both of Brainerd Communicators, Inc., +1-212-986-6667, forTelzuit Medical Technologies, Inc.
Web site: http://www.telzuit.com/
